Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 189 citing articles:

Oxidative stress injury in doxorubicin-induced cardiotoxicity
Songbo Mei, Lang Hong, Xinyong Cai, et al.
Toxicology Letters (2019) Vol. 307, pp. 41-48
Closed Access | Times Cited: 452
Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects
Qingyu Zhang, Feixuan Wang, Keke Jia, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 280
New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury
Jin Wang, Sam Toan, Hao Zhou
Angiogenesis (2020) Vol. 23, Iss. 3, pp. 299-314
Closed Access | Times Cited: 270
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Saixian Shi, Ye Chen, Zhijian Luo, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 112
Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat
Aditya Upadhayay, Jingjing Ling, Dharm Pal, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100890-100890
Closed Access | Times Cited: 76
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 55
miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3
Lina Xu, Yue Li, Lianhong Yin, et al.
Theranostics (2018) Vol. 8, Iss. 20, pp. 5593-5609
Open Access | Times Cited: 135
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
Parama Dey, Monikongkona Boruah, Kumari Yachna, et al.
Life Sciences (2020) Vol. 260, pp. 118182-118182
Closed Access | Times Cited: 123
Puerarin reverses cadmium-induced lysosomal dysfunction in primary rat proximal tubular cells via inhibiting Nrf2 pathway
Liyuan Wang, Rui‐Feng Fan, Du-Bao Yang, et al.
Biochemical Pharmacology (2018) Vol. 162, pp. 132-141
Closed Access | Times Cited: 122
Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections
Xufeng Tao, Lianhong Yin, Lina Xu, et al.
Pharmacological Research (2018) Vol. 137, pp. 259-269
Closed Access | Times Cited: 121
Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal
Shasha Song, Liang Chu, Huifang Liang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 119
Role of acetylation in doxorubicin-induced cardiotoxicity
Daisong Li, Yanyan Yang, Shizhong Wang, et al.
Redox Biology (2021) Vol. 46, pp. 102089-102089
Open Access | Times Cited: 101
Natural compounds against doxorubicin‐induced cardiotoxicity: A review on the involvement of Nrf2/ARE signaling pathway
Fatemeh Yarmohammadi, Ramin Rezaee, Gholamreza Karimi
Phytotherapy Research (2020) Vol. 35, Iss. 3, pp. 1163-1175
Closed Access | Times Cited: 98
Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway
Lei Sun, Hua Wang, Dan Xu, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 48-60
Open Access | Times Cited: 87
Recent Advances in the Pharmacological Activities of Dioscin
Longfei Yang, Shengnan Ren, Fei Xu, et al.
BioMed Research International (2019) Vol. 2019, pp. 1-13
Open Access | Times Cited: 80
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
Qianqian Jiang, Xu Chen, Xue Tian, et al.
Phytomedicine (2022) Vol. 106, pp. 154439-154439
Closed Access | Times Cited: 70
Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury
Xin Zhao, Linjie Si, Jinhui Bian, et al.
Free Radical Biology and Medicine (2022) Vol. 182, pp. 232-245
Closed Access | Times Cited: 66
Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity
Chao Tian, Yanyan Yang, Baochen Bai, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 5, pp. 1328-1338
Open Access | Times Cited: 62
A comprehensive review of Sirtuins: With a major focus on redox homeostasis and metabolism
Shahab Shahgaldi, Fatemeh Rezaei Kahmini
Life Sciences (2021) Vol. 282, pp. 119803-119803
Closed Access | Times Cited: 61
Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis, and improving mitochondrial quality and quantity control
Yujie Zhong, Jiayu Liu, Dianjun Sun, et al.
Food & Function (2022) Vol. 13, Iss. 6, pp. 3660-3673
Closed Access | Times Cited: 53
Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
Jun Zhang, Wanqian Pan, Yue Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6626-6645
Open Access | Times Cited: 49
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Xiaopeng Zhao, Zheng Tian, Mingli Sun, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 42
Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction
Demin Li, Ge Zhang, Zeyu Wang, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175569-175569
Open Access | Times Cited: 35
Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway
Lu Chen, Xingang Sun, Zhen Wang, et al.
Toxicology and Applied Pharmacology (2023) Vol. 482, pp. 116794-116794
Open Access | Times Cited: 29
Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
Ahmed Elfadadny, Rokaia F. Ragab, Rania Hamada, et al.
Toxicology and Applied Pharmacology (2023) Vol. 461, pp. 116405-116405
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top